Ovarian PRP for Diminished Ovarian Reserve
Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial
Generation Next Fertility
230 participants
Oct 7, 2023
INTERVENTIONAL
Conditions
Summary
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Eligibility
Inclusion Criteria3
- Clinical diagnosis of diminished ovarian reserve
- Clinical diagnosis of poor ovarian response
- Women age 35-42
Exclusion Criteria4
- Clinical diagnosis of premature ovarian failure
- Clinical diagnosis of menopause.
- Under 35 years of age
- Over 42 years of age
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prepared sample from patient's own blood collected and processed. Either PRP or serum is injected into the patient's ovary. All other care is standard for the IVF process
Patient's serum is injected into ovary instead of PRP as placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05790655